Company intelligence / Profile preview

Kaitai Capital

Hangzhou, Zhejiang Province, Chinakaitaicapital.com ↗

Ownership: Private
Employees: ~161
Development stage: Other

Overview

Kaitai Capital specializes in venture capital and private equity investments with a strong focus on biotechnology, precision medicine, and healthcare services. The firm manages approximately 50 billion RMB (~$7.2B USD) and has invested in numerous innovative companies across the life sciences sector.

It does not develop drugs or have its own clinical pipeline.

Industry: Investors

Partnerships

Not specified; as an investor it partners with portfolio companies rather than forming traditional pharma partnerships.

Beyond the preview

Go deeper on Kaitai Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaitai Capital.

Explore the full profile